Search hospitals > California > Anaheim
Kaiser Permanente-Anaheim
Claim this profileAnaheim, California 92806
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
136 reported clinical trials
11 medical researchers
Summary
Kaiser Permanente-Anaheim is a medical facility located in Anaheim, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser Permanente-Anaheim is involved with conducting 136 clinical trials across 350 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Helen H. Moon, Gary L. Buchschacher, and Eric C. McGary.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Robert M. CooperKaiser Permanente Downey Medical Center7 years of reported clinical research
Expert in Tumors
Expert in Cancer
46 reported clinical trials
91 drugs studied
Helen H. MoonKaiser Permanente-Riverside7 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
13 reported clinical trials
23 drugs studied
Gary L. BuchschacherKaiser Permanente-Anaheim6 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
12 reported clinical trials
33 drugs studied
Eric C. McGaryKaiser Permanente-Anaheim9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
18 drugs studied
Clinical Trials running at Kaiser Permanente-Anaheim
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Cancer
Lymphoma
Squamous Cell Carcinoma
Ovarian Tumors
Colorectal Cancer
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-Anaheim?
Kaiser Permanente-Anaheim is a medical facility located in Anaheim, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser Permanente-Anaheim is involved with conducting 136 clinical trials across 350 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Helen H. Moon, Gary L. Buchschacher, and Eric C. McGary.